Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 137

1.

Herbal Medicine for the Treatment of Vascular Dementia: An Overview of Scientific Evidence.

Chang D, Liu J, Bilinski K, Xu L, Steiner GZ, Seto SW, Bensoussan A.

Evid Based Complement Alternat Med. 2016;2016:7293626. doi: 10.1155/2016/7293626. Review.

2.

Dementia, Preclinical Studies in Neurodegeneration and its Potential for Translational Medicine in South America.

Cardona-Gómez GP, Lopera F.

Front Aging Neurosci. 2016 Dec 20;8:304. doi: 10.3389/fnagi.2016.00304. Review.

3.

Impact of coronary heart disease on cognitive decline in Alzheimer's disease: a prospective longitudinal cohort study in primary care.

Bleckwenn M, Kleineidam L, Wagner M, Jessen F, Weyerer S, Werle J, Wiese B, Lühmann D, Posselt T, König HH, Brettschneider C, Mösch E, Weeg D, Fuchs A, Pentzek M, Luck T, Riedel-Heller SG, Maier W, Scherer M.

Br J Gen Pract. 2017 Feb;67(655):e111-e117. doi: 10.3399/bjgp16X688813.

PMID:
27993897
4.

Cognitive Function in Low-Income and Low-Literacy Settings: Validation of the Tablet-Based Oxford Cognitive Screen in the Health and Aging in Africa: A Longitudinal Study of an INDEPTH Community in South Africa (HAALSI).

Humphreys GW, Duta MD, Montana L, Demeyere N, McCrory C, Rohr J, Kahn K, Tollman S, Berkman L.

J Gerontol B Psychol Sci Soc Sci. 2017 Jan;72(1):38-50.

PMID:
27974474
5.

Alzheimer and vascular dementia in the elderly patients.

Seetlani NK, Kumar N, Imran K, Ali A, Shams N, Sheikh T.

Pak J Med Sci. 2016 Sep-Oct;32(5):1286-1290.

6.

Protective effects of carnosine on white matter damage induced by chronic cerebral hypoperfusion.

Ma J, Bo SH, Lu XT, Xu AJ, Zhang J.

Neural Regen Res. 2016 Sep;11(9):1438-1444.

7.
8.

Effects of Long-Term Exercise on Age-Related Hearing Loss in Mice.

Han C, Ding D, Lopez MC, Manohar S, Zhang Y, Kim MJ, Park HJ, White K, Kim YH, Linser P, Tanokura M, Leeuwenburgh C, Baker HV, Salvi RJ, Someya S.

J Neurosci. 2016 Nov 2;36(44):11308-11319.

PMID:
27807171
9.

Alzheimer Disease and Its Growing Epidemic: Risk Factors, Biomarkers, and the Urgent Need for Therapeutics.

Hickman RA, Faustin A, Wisniewski T.

Neurol Clin. 2016 Nov;34(4):941-953. doi: 10.1016/j.ncl.2016.06.009. Review.

PMID:
27720002
10.

Predicting episodic memory performance using different biomarkers: results from Argentina-Alzheimer's Disease Neuroimaging Initiative.

Russo MJ, Cohen G, Chrem Mendez P, Campos J, Nahas FE, Surace EI, Vazquez S, Gustafson D, Guinjoan S, Allegri RF, Sevlever G.

Neuropsychiatr Dis Treat. 2016 Sep 13;12:2199-2206.

11.

Cyanobacterial Neurotoxin BMAA and Mercury in Sharks.

Hammerschlag N, Davis DA, Mondo K, Seely MS, Murch SJ, Glover WB, Divoll T, Evers DC, Mash DC.

Toxins (Basel). 2016 Aug 16;8(8). pii: E238. doi: 10.3390/toxins8080238.

12.

Low Leptin Availability as a Risk Factor for Dementia in Chilean Older People.

Albala C, Angel B, Lera L, Sanchez H, Marquez C, Fuentes P.

Dement Geriatr Cogn Dis Extra. 2016 Jul 16;6(2):295-302. doi: 10.1159/000447447.

13.

Cognitive variations among vascular dementia subtypes caused by small-, large-, or mixed-vessel disease.

Ying H, Jianping C, Jianqing Y, Shanquan Z.

Arch Med Sci. 2016 Aug 1;12(4):747-53. doi: 10.5114/aoms.2016.60962.

14.

A comparison of health utility scores calculated using United Kingdom and Canadian preference weights in persons with alzheimer's disease and their caregivers.

Fang M, Oremus M, Tarride JE, Raina P; Canadian Willingness-to-pay Study Group..

Health Qual Life Outcomes. 2016 Jul 18;14(1):105. doi: 10.1186/s12955-016-0510-y.

15.

Principles and management of neuropsychiatric symptoms in Alzheimer's dementia.

Nowrangi MA, Lyketsos CG, Rosenberg PB.

Alzheimers Res Ther. 2015 Jan 29;7(1):12. doi: 10.1186/s13195-015-0096-3.

16.

Rannasangpei Is a Therapeutic Agent in the Treatment of Vascular Dementia.

Wu P, Luo Y, Zhen L, Hu X, Shang Y, Liao Y, Xue H, Huang F, Xiao W.

Evid Based Complement Alternat Med. 2016;2016:2530105. doi: 10.1155/2016/2530105.

17.

Neurogenomics in Africa: Perspectives, progress, possibilities and priorities.

Akinyemi RO, Owolabi MO, Oyeniyi T, Ovbiagele B, Arnett DK, Tiwari HK, Walker R, Ogunniyi A, Kalaria RN; SIREN group of H3Africa Consortium..

J Neurol Sci. 2016 Jul 15;366:213-23. doi: 10.1016/j.jns.2016.05.006. Review.

18.

Serum-based protein profiles of Alzheimer's disease and mild cognitive impairment in elderly Hispanics.

Villarreal AE, O'Bryant SE, Edwards M, Grajales S, Britton GB; Panama Aging Research Initiative..

Neurodegener Dis Manag. 2016 Jun;6(3):203-13. doi: 10.2217/nmt-2015-0009.

PMID:
27229914
19.

A Bayesian Approach to Identifying New Risk Factors for Dementia: A Nationwide Population-Based Study.

Wen YH, Wu SS, Lin CH, Tsai JH, Yang P, Chang YP, Tseng KH.

Medicine (Baltimore). 2016 May;95(21):e3658. doi: 10.1097/MD.0000000000003658.

20.

APOE Genotype in the Ethnic Majority and Minority Groups of Laos and the Implications for Non-Communicable Diseases.

Midorikawa K, Soukaloun D, Akkhavong K, Southivong B, Rattanavong O, Sengkhygnavong V, Pyaluanglath A, Sayasithsena S, Nakamura S, Midorikawa Y, Murata M.

PLoS One. 2016 May 11;11(5):e0155072. doi: 10.1371/journal.pone.0155072.

Items per page

Supplemental Content

Support Center